You are on page 1of 3

CHEMOTHERAPY REGIMENS

CANCER REGIMEN DRUGS SCHEDULE


HEMATOLOGY
ACUTE MYELOID LEUKEMIA (AML) DAC CYTARABINE (7 DAYS) f/b DAUNORUBICIN (3 DAYS)
ACUTE LYMPHOID LEUKEMIA (ALL) VPAD VINCRISTINE + PREDNISOLONE + ASPARGINASE + DAUNORUBICIN
1ST GEN - IMATINIB
CHRONIC MYELOID LEUKEMIA (CML) 2ND GEN - DASATINIB/ NILOTINIB/ BOSUTINIB
3RD GEN - PONATINIB
CHRONIC LYMPHOID LEUKEMIA (CLL) FCR FLUDARABINE + CYCLOPHOSPHAMIDE + RITUXIMAB
HODGKIN LYMPHOMA ABVD ADRIAMYCIN + BLEOMYCIN + VINBLASTINE + DACARBAZINE
LOW GRADE NHL -
FLUDARABINE + CYCLOPHOSPHAMIDE + RITUXIMAB
FCR
NON HODGKIN LYMPHOMA HIGH GRADE NHL - R-
RITUXIMAB + CYCLOPHOSPHAMIDE + HYDROXYDAUNORUBICIN + VINCRISTINE + PREDNISOLONE
CHOP
BR BENDAMUSTINE + RITUXIMAB
BURKITT LYMPHOMA CODOX-M/IVAC CYCLOPHOSPHAMIDE + VINCRISTINE + DOXORUBICIN + HIGH DOSE METHOTREXATE/ IFOSFAMIDE + ETOPOSIDE + HIGH DOSE CYTARABINE
CYBORD CYCLOPHOSPHAMIDE + BORTEZOMIB + DEXAMETHASONE
MULTIPLE MYELOMA
RVD LENALIDOMIDE + BORTEZOMIB + DEXAMETHASONE

GASTROINTESTINAL
ESOPHAGEAL CANCER ECF EPIRUBICIN + CISPLATIN + 5-FLUOROURACIL
ECF EPIRUBICIN + CISPLATIN + 5-FLUOROURACIL
GASTRIC CANCER
FAM / FAMTX 5-FLUOROURACIL + ADRIAMYCIN + MITOMYCIN / METHOTREXATE
GASTRIC LYMPHOMA R-CHOP RITUXIMAB + CYCLOPHOSPHAMIDE + HYDROXYDAUNORUBICIN + VINCRISTINE + PREDNISOLONE
IMATINIB
GIST
RESISTANT - SUNITINIB / SORAFENIB
CAPEOX CAPECITABINE + OXIPLATINUM
COLORECTAL CANCER FOLFOX 5-FLUOROURACIL + FOLINIC ACID + OXALIPLATIN
FOLFIRI 5-FLUOROURACIL + FOLINIC ACID + IRINOTECAN
ANAL CANCER NIGRO REGIME 5-FLUOROURACIL + MITOMYCIN-C + CISPLATIN
APPENDICULAR CANCER HIPEC HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY WITH PACLITAXEL + MITOMYCIN-C
FOLFIRINOX 5-FLUOROURACIL + FOLINIC ACID + IRINOTECAN + OXALIPLATIN
PANCREATIC CANCER GEMCITABINE + CAPECITABINE
NAB-PACLITAXEL
GALL BLADDER CANCER GEMCITABINE

Compiled by
Dr. Bhargav Shreeram. G
CHEMOTHERAPY REGIMENS

CHOLANGIOCARCINOMA GEMCITABINE

UROGENITAL
TESTICULAR CANCER BEP BLEOMYCIN + ETOPOSIDE + CISPLATIN
BLADDER CANCER M-VAC METHOTREXATE + VINBLASTINE + ADRIAMYCIN + CISPLATIN
DD-4A VINCRISTINE + DACTINOMYCIN + ADRIAMYCIN
WILM'S TUMOR
REGIMEN I VINCRISTINE + ADRIAMYCIN + ETOPOSIDE + CYCLOPHOSPHAMIDE
PROSTATE CANCER PACLITAXEL / CABAZITAXEL
CAF CYCLOPHOSPHAMIDE + ADRIAMYCIN + 5-FLUOROURACIL
BREAST CANCER CMF CYCLOPHOSPHAMIDE + METHOTREXATE + 5-FLUOROURACIL
AC/EC + T ADRIAMYCIN + CYCLOPHOSPHAMIDE (4 CYCLES) f/b PACLITAXEL (4 CYCLES)
LOW RISK METHOTREXATE
CHORIOCARCINOMA HIGH RISK
ETOPOSIDE + METHOTREXATE + ACTINOMYCIN + CYCLOPHOSPHAMIDE + VINCRISTINE
(BAGSHAW REGIME)
PACLITAXEL + CARBOPLATIN /
ENDOMETRIAL CANCER
PACLITAXEL + ADRIAMYCIN + CISPLATIN (TAP REGIME)
CERVIX CANCER CISPLATIN
EPITHELIAL OVARIAN CANCER PACLITAXEL + CARBOPLATIN
GERM CELL OVARIAN CANCER BEP BLEOMYCIN + ETOPOSIDE + CISPLATIN
SEX CORD STROMAL OVARIAN CANCER BLEOMYCIN + ETOPOSIDE + PACLITAXEL

CENTRAL NERVOUS SYSTEM


GLIOBLASTOMA MULTIFORME TEMZOLOMIDE
OLIGODENDROGLIOMA PCV PROCARBAZINE + LOMUSTINE + VINCRISTINE
MEDULLOBLASTOMA PACKER REGIMEN CISPLATIN + LOMUSTINE + VINCRISTINE
NEUROBLASTOMA CDE CYCLOPHOSPHAMIDE + CISPLATIN + ADRIAMYCIN + ETOPOSIDE
RETINOBLASTOMA VEC VINCRISTINE + ETOPOSIDE + CARBOPLATIN

MISCELLANEOUS
SMALL CELL LUNG CANCER PEI CISPLATIN + ETOPOSIDE + IFOSFAMIDE
SQUAMOUS CELL LUNG CANCER CISPLATIN + VINORELBINE + GEMCITABINE
NON SQUAMOUS CELL LUNG CANCER CISPLATIN + VINORELBINE + PEMETREXED
ANAPLASTIC THYROID CANCER DABRAFENIB
Compiled by
Dr. Bhargav Shreeram. G
CHEMOTHERAPY REGIMENS

MEDULLARY THYROID CANCER VANDETANIB / CABOZANTINIB


AUERBUCH'S
PHEOCHROMOCYTOMA VINCRISTINE + CYCLOPHOSPHAMIDE + DACARBAZINE
PROTOCOL
ADRENOCORTICAL CANCER CISPLATIN + ETOPOSIDE + ADRIAMYCIN
DABRAFENIB + TRAMETINIB /
MALIGNANT MELANOMA
VEMURAFENIB + COBIMETINIB
SOFT TISSUE SARCOMA MAID MESNA + ADRIAMYCIN + IFOSFAMIDE + DACARBAZINE
OSTEOSARCOMA T10 PROTOCOL ACTINOMYCIN + BLEOMYCIN + CYCLOPHOSPHOMIDE + ADRIAMYCIN + HIGH DOSE METHOTREXATE + CISPLATIN

Compiled by
Dr. Bhargav Shreeram. G

You might also like